Roche builds Asian research presence with new Singapore hub
This article was originally published in Scrip
Executive Summary
Roche and its partners will invest a total of CHF100 million ($96.1 million) in a broad alliance with medical and scientific institutions in Singapore for research into disease mechanisms and the discovery of novel personalised therapies.